12LBA Biomarker-driven access to crizotinib in ALK, MET or ROS1 positive (+) malignancies in adults and children: The French national AcSe Program. Issue 3 (September 2015)
- Record Type:
- Journal Article
- Title:
- 12LBA Biomarker-driven access to crizotinib in ALK, MET or ROS1 positive (+) malignancies in adults and children: The French national AcSe Program. Issue 3 (September 2015)
- Main Title:
- 12LBA Biomarker-driven access to crizotinib in ALK, MET or ROS1 positive (+) malignancies in adults and children: The French national AcSe Program
- Authors:
- Vassal, G.
Moro-sibilot, D.
Le Deley, M.C.
Hoog-labouret, N.
Nowak, F.
Jimenez, M.
Tournigand, C.
Houot, R.
Malka, D.
Aparicio, T.
Escudier, B.
Ray-coquard, I.
Godbert, Y.
Taillandier, L.
Bieche, I.
Lantuejoul, S.
Ferretti, G.
Menu, Y.
Blay, J.Y.
Buzyn, A. - Abstract:
- Is Part Of:
- European journal of cancer. Volume 51:Issue 3(2015:Feb.)
- Journal:
- European journal of cancer
- Issue:
- Volume 51:Issue 3(2015:Feb.)
- Issue Display:
- Volume 51, Issue 3 (2015)
- Year:
- 2015
- Volume:
- 51
- Issue:
- 3
- Issue Sort Value:
- 2015-0051-0003-0000
- Page Start:
- S715
- Page End:
- Publication Date:
- 2015-09
- Subjects:
- Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Cancer
Tumors
Electronic journals
Periodicals
Electronic journals
616.994 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09598049 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=2879 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09598049 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09598049 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/S0959-8049(15)30070-8 ↗
- Languages:
- English
- ISSNs:
- 0959-8049
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.725100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 5054.xml